| ||
|
| Amylin Pharmaceuticals: Pipeline Amylin Pharmaceuticals, Inc. is a development pharmaceutical company focused on metabolic disorders, and specializing in preclinical characterization of lead molecules and demonstration of proof of principle in humans. | |
| Axys Pharmaceuticals: Pipeline Axys Pharmaceuticals has developed a broad pipeline of small molecule drugs to treat significant diseases, including asthma, blood clotting disorders, arthritis, osteoporosis, cancer, and inflammatory and infectious diseases. | ||
| Cortex Pharmaceuticals Cortex believes that increasing AMPA receptor activity with AMPAKINEs will provide a new approach to treating a number of central nervous system disorders | ||
| Vertex Pipeline consisting of antiviral, cancer, automimmune & inflammation, neurological disorders. | ||
| PathoGenesis: Pipeline Drug candidates and R&D approach, areas of R&D. | ||
| Abbott Laboratories: Pipeline Our research focuses on developing compounds in five key areas: infectious diseases, neurological and urological diseases, immunologic diseases, metabolic diseases, and cancer. | ||
| Cor Therapeutics, Inc: Pipeline Research and clinical development table of products in the pipeline. | ||
| OSI Pharmaceuticals: Product Pipeline OSI Pharmaceuticals is a Pharmaceutical Research and Development Organization (PRDO) that utilizes a high tech, comprehensive drug discovery and development capability to rapidly and cost effectively discover and develop novel, small molecule dr. | ||
| Nabi Product portfolio in development, and marketed products. | ||
| Amgen Amgen Marketed Products and Pipeline Candidates | ||
| Medco Research: Product Portfolio Medco Research is dedicated to being a leader in the global commercialization of cardiovascular medicines and adenosine-based products leading to superior growth in shareholder value. | ||
| Genetics Institute, Inc. Genetics Institute, Inc., is developing a portfolio of proprietary products including blood cell growth factors, bone-inducing proteins, and agents to treat cancer, infectious disease and hemophilia | ||
| ZymeTx, Inc. ViraZyme Technology based product pipeline. | ||
| NDA PIPELINE: NEW DRUGS New Drugs provides a timely profile of all pharmaceutical substances designed for the United States market. | ||
| Tularik: Pipeline Our pipeline includes two cancer drug candidates in clinical testing, one cancer drug candidate for which an Investigational New Drug application has been approved, one preclinical cytomegalovirus drug candidate and 14 drug leads in our other pr. | ||
| ||